178 related articles for article (PubMed ID: 34164501)
21. Mass balance and pharmacokinetics of an oral dose of
Dai X; Karol MD; Hitron M; Hard ML; Blanchard JE; Eraut NCJE; Rich N; Gufford BT
Pharmacol Res Perspect; 2021 Feb; 9(1):e00722. PubMed ID: 33576192
[TBL] [Abstract][Full Text] [Related]
22. Study of the mass balance, biotransformation and safety of [
Shi R; Chai Y; Feng H; Xie L; Zhang L; Zhong T; Chen J; Yan P; Zhu B; Zhao J; Zhou C
Front Pharmacol; 2023; 14():1231102. PubMed ID: 37781692
[No Abstract] [Full Text] [Related]
23. Pharmacokinetics, absorption, metabolism, and excretion of [
Prakash C; Fan B; Altaf S; Agresta S; Liu H; Yang H
Cancer Chemother Pharmacol; 2019 May; 83(5):837-848. PubMed ID: 30758648
[TBL] [Abstract][Full Text] [Related]
24. Metabolism, Excretion, and Pharmacokinetics of Selumetinib, an MEK1/2 inhibitor, in Healthy Adult Male Subjects.
Dymond AW; Howes C; Pattison C; So K; Mariani G; Savage M; Mair S; Ford G; Martin P
Clin Ther; 2016 Nov; 38(11):2447-2458. PubMed ID: 27751676
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
26. Absorption, Metabolism, and Excretion of [
Nicolas O; Moliner P; Soubayrol P; Vitse O; Roy S; Cabanis MJ; Turner T; Klieber S; Muccio S; Arabeyre C; Brun P
Clin Drug Investig; 2023 Aug; 43(8):653-665. PubMed ID: 37642857
[TBL] [Abstract][Full Text] [Related]
27. Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers.
Liu L; Li W; Yang L; Guo ZT; Xue H; Xie NJ; Chen XY
Acta Pharmacol Sin; 2022 Apr; 43(4):1082-1090. PubMed ID: 34267345
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects.
Chen N; Wen L; Lau H; Surapaneni S; Kumar G
Cancer Chemother Pharmacol; 2012 Mar; 69(3):789-97. PubMed ID: 22037879
[TBL] [Abstract][Full Text] [Related]
29.
Ma J; Laskin OL; Roffel AF; Vaes WHJ; Tang B; Kolnaar J; O'Keefe K; Golden L; Kong R
Drug Metab Dispos; 2023 Oct; ():. PubMed ID: 37852795
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of absorption, distribution, metabolism, and excretion of [
Liao M; Watkins S; Nash E; Isaacson J; Etter J; Beltman J; Fan R; Shen L; Mutlib A; Kemeny V; Pápai Z; van Tilburg P; Xiao JJ
Invest New Drugs; 2020 Jun; 38(3):765-775. PubMed ID: 31250355
[TBL] [Abstract][Full Text] [Related]
31. Single-dose pharmacokinetics of Nestorone, a potential female-contraceptive.
Prasad PV; Bashir M; Sitruk-Ware R; Kumar N
Steroids; 2010 Mar; 75(3):252-64. PubMed ID: 20064539
[TBL] [Abstract][Full Text] [Related]
32. Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.
Zollinger M; Lozac'h F; Hurh E; Emotte C; Bauly H; Swart P
Cancer Chemother Pharmacol; 2014 Jul; 74(1):63-75. PubMed ID: 24817600
[TBL] [Abstract][Full Text] [Related]
33. Metabolism, excretion, and pharmacokinetics of [14C]INCB018424, a selective Janus tyrosine kinase 1/2 inhibitor, in humans.
Shilling AD; Nedza FM; Emm T; Diamond S; McKeever E; Punwani N; Williams W; Arvanitis A; Galya LG; Li M; Shepard S; Rodgers J; Yue TY; Yeleswaram S
Drug Metab Dispos; 2010 Nov; 38(11):2023-31. PubMed ID: 20699411
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and excretion of a novel p38 MAP kinase inhibitor pamapimod in healthy male subjects.
Zhang X; Fettner S; Winter E; Masjedizadeh M; Hisoire G
Int J Clin Pharmacol Ther; 2011 Jun; 49(6):345-52. PubMed ID: 21612741
[TBL] [Abstract][Full Text] [Related]
35. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study.
Tiseo PJ; Perdomo CA; Friedhoff LT
Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):19-24. PubMed ID: 9839761
[TBL] [Abstract][Full Text] [Related]
36. Plasma levels, tissue distribution, and excretion of radioactivity after single-dose administration of ((3)H)-oleic acid added to D-004, a lipid extract of the fruit of Roystonea regia, in rats.
Pérez LY; Menéndez R; Más R; González RM
Curr Ther Res Clin Exp; 2006 Nov; 67(6):406-19. PubMed ID: 24678113
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
Blight AR; Henney HR
Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
[TBL] [Abstract][Full Text] [Related]
38. Detection of an EML4-ALK fusion mutation secondary to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer: a case report.
Ren KH; Qin WW; Wang Y; Peng JC; Hu WX
Ann Palliat Med; 2022 Jul; 11(7):2503-2509. PubMed ID: 35927783
[TBL] [Abstract][Full Text] [Related]
39. Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil.
Muirhead GJ; Rance DJ; Walker DK; Wastall P
Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):13S-20S. PubMed ID: 11879255
[TBL] [Abstract][Full Text] [Related]
40. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
